Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
174
days
ECM1 produced by hepatic stellate cells serves as a gatekeeper of liver homeostasis in hepatic fibrosis
Authors
Aiting Yang; Xuzhen Yan; Yiwen Wang; Qi Han; Xiaofei Tong; Shuyan Chen; Xinyu Zhao; Wei Chen; Jidong Jia; Detlef Schuppan; Hong YouShow moreShow less
Affiliations
1. Experimental and Translational Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China; 2. Beijing Clinical Medicine Institute, Beijing, P.R. China; 3. State Key Lab of Digestive Health, Beijing, P.R. China; 4. National Clinical Research Center of Digestive Diseases, Beijing, P.R. China; 5. Institute of Translational Immunology and Research Center for Immune Therapy, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; 6. Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China; 7. Department of Hepatobiliary Surgery and Liver Transplant Center, The First Hospital of Shanxi Medical University, Taiyuan, P.R. China; 8. Clinical Epidemiology and Evidence-Based Medicine Unit, Beijing Friendship Hospital, Capital Medical University, Beijing, P.R. China; 9. Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USAShow moreShow less
95
days
Reduced risk of liver-related events among patients receiving individualized nutrition-focused remote care in the United States
Authors
Shaminie J. Athinarayanan; Adam J. Wolfberg; Priya V. Shanmugam; Bilal A. Hameed; Maurizio BonaciniShow moreShow less
Affiliations
1. Departments of Research, Virta Health, Denver, Colorado, USA; 2. Transplant Hepatology, School of Medicine, University of California, San Francisco, California, USA; 3. Mission Gastroenterology and Hepatology, University of California, San Francisco, California, USAShow moreShow less
119
days
Hepatic GPR75 exacerbates MASH through GNAI2-dependent signaling
Authors
Xule Yang; Na Yang; Zhihao Cheng; Rui Zhang; Hui Fan; Dongsheng Liu; Jiye Aa; Guangji Wang; Yuan XieShow moreShow less
Affiliations
1. Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China; 2. China Pharmaceutical University Nanjing Drum Tower Hospital, Nanjing, China; 3. Research Unit of PK-PD Based Bioactive Components and Pharmacodynamic Target Discovery of Natural Medicine of Chinese Academy of Medical Sciences, China Pharmaceutical University, Nanjing, ChinaShow moreShow less
98
days
Repurposing Resmetirom suppresses MASH-associated hepatocellular carcinoma, with mechanistic implications of MDK/LRP1-mediated metabolic reprogramming and immunosuppression
Authors
Vanilla Xin Zhang; Tina Suoangbaji; Yu‑Man Tsui; Karen Man-Fong Sze; Eva Lee; Lu Tian; Jingyi Lu; Huan Deng; Abdullah Husain; Charry Shuk-Ching Hui; Joyce Man-Fong Lee; Daniel Wai-Hung Ho; Irene Oi-Lin NgShow moreShow less
Affiliations
1. Department of Pathology, The University of Hong Kong, Hong Kong SAR, China; 2. State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong SAR, China; 3. Department of Pathology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, ChinaShow moreShow less
174
days
Pruritus is common in primary sclerosing cholangitis, persists over time, and its intensity is associated with disease severity: a multicentre, prospective observational study
Authors
Nasir Hussain; Rodrigo V. Motta; Usha Gungabissoon; Linda Casillas; Sumanta Mukherjee; Andrea Ribeiro; Megan M. Mclaughlin; Kaitlin Hagan; Khushpreet Bhandal; Penelope Rogers; Martine Walmsley; James Ferguson; Andreas E. Kremer; Emma L. Culver; Palak J. TrivediShow moreShow less
Affiliations
1. National Institute of Health and Care Research (NIHR) Birmingham Biomedical Research Centre (BRC), University of Birmingham, Birmingham, UK; 2. Centre for Liver and Gastrointestinal Research, School of Infection, Inflammation. and Immunology, University of Birmingham, Birmingham, UK; 3. Liver Unit, University Hospitals Birmingham National Health Service Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK; 4. Translational Gastroenterology and Liver Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; 5. GSK, London, UK; 6. GSK, Collegeville, Pennsylvania, USA; 7. GSK, Madrid, Spain; 8. PSC Support, Oxford, UK; 9. Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; 10. National Institute of Health and Care Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UKShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days